World Health Organization : Year 1996 ; World Health Organization, Programme on Substance Abuse, No. 96.10: Programme on Substance Pological Treatment of Substance Use Disorders ; International Issues in Medications Development

By World Health Organization

Book Id: WPLBN0000076182
Format Type: PDF eBook
File Size: 1.4 MB
Reproduction Date: 2005

Title:	World Health Organization : Year 1996 ; World Health Organization, Programme on Substance Abuse, No. 96.10: Programme on Substance Pological Treatment of Substance Use Disorders ; International Issues in Medications Development
Author:	World Health Organization
Volume:
Language:	English
Subject:	Health., Public health, Wellness programs
Collections:	Medical Library Collection, World Health Collection
Historic Publication Date:
Publisher:	World Health Organization


Citation APA MLA Chicago Organization, W. H. (n.d.). World Health Organization : Year 1996 ; World Health Organization, Programme on Substance Abuse, No. 96.10. Retrieved from http://self.gutenberg.org/

Description
Medical Reference Publication

Excerpt
1. INTRODUCTION In January 1992, the United Nations International Drug Control Programme (UNDCP) and the World Health Organization (WHO) jointly organized an Informal Expert Group Meeting on the Craving Mechanism, which included discussions of pharmacological treatment (United Nations and World Health Organization, 1992). In the same year, the Addiction Research Foundation (ARF) and WHO agreed to undertake a joint project to review international aspects of medication development for dependence. During the Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD) in June 1994, a small group of experts met to develop an agenda for an international meeting to highlight the importance, identify the barriers, facilitate clinical testing, and encourage the development and use of medications for the treatment of substance abuse and dependence. The invited participants would be scientists well-informed about the current status of medication development efforts for alcohol, nicotine (in tobacco products) and illegal drug dependence. Based upon these recommendations, a joint ARE-WHO Consultation w@ held in Toronto, Canada from 22 to 26 October 1995.

Table of Contents
TABLE OF CONTENTS 1. introduction 1 2. TERMINOLOGY 1 INTERNATIONAL SIGNIFICANCE OF THE MEETING 1 3.1 Provision of informational basis for policy makers 1 3.2 Lack of consideration by other reports 2 4. RELATED ACTIVITIES OF WHO 2 5. FACTORS THAT PROMOTE OR IMPEDE THE DEVELOPMENT OF MEDICATIONS 2 5.1 Overview 2 5.2 Science 3 5.2.1 Animal models 5.2.2 Human studies 5.3 Attitudes 4 5.3.1 Confusion about diagnosis 5.3.2 Lack of acknowledgement of the chronic nature of dependence 5.3.3 Stigma or negative attitudes toward drug dependence and its medication 5.4 Economics 6 5.4.1 Market size 5.4.2 Insurance coverage 5.5 Regulatory controls 7 5.5.1 International harmonization in marketing regulations 5.5.2 Additional regulations applicable to controlled drugs 5.6 Utilization of medications and treatments 8 5.6.1 Availability of alternatives 5.6.2 Special training and regulatory requirements 5.6.3 Increiised risk of adverse effects 5.7 Perception by the pharmaceutical industry 8 5.8 Measurement of drug and alcohol problems in a cross-cultural setting 9 SPECIFIC DRUGS OF DEPENDENCE 10 6.1 Nicotine 10 6,l. 1 Science 6.1.2 Attitude about the nature of the problem and user